ES2058057T3 - Derivados de lancacidina y su produccion. - Google Patents

Derivados de lancacidina y su produccion.

Info

Publication number
ES2058057T3
ES2058057T3 ES86116752T ES86116752T ES2058057T3 ES 2058057 T3 ES2058057 T3 ES 2058057T3 ES 86116752 T ES86116752 T ES 86116752T ES 86116752 T ES86116752 T ES 86116752T ES 2058057 T3 ES2058057 T3 ES 2058057T3
Authority
ES
Spain
Prior art keywords
lancacidine
derivatives
production
derivative
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86116752T
Other languages
English (en)
Inventor
Isao Minamida
Naoto Hashimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61238788A external-priority patent/JPH07622B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2058057T3 publication Critical patent/ES2058057T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10W—GENERIC PACKAGES, INTERCONNECTIONS, CONNECTORS OR OTHER CONSTRUCTIONAL DETAILS OF DEVICES COVERED BY CLASS H10
    • H10W74/00—Encapsulations, e.g. protective coatings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA PRESENTE INVENCION OFRECE EL DERIVADO DE LANCACIDINA (1) Y LA OBTENCION DEL MISMO. EL DERIVADO DE LANCACIDINA (1) MUESTRA EXCELENTE ACTIVIDAD ANTIMICROBIANA Y PUEDE POR LO TANTO USARSE PARA LA PROFILAXIS Y EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS EN ANIMALES.
ES86116752T 1985-12-05 1986-12-02 Derivados de lancacidina y su produccion. Expired - Lifetime ES2058057T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27425685 1985-12-05
JP61238788A JPH07622B2 (ja) 1985-12-05 1986-10-06 ランカシジン誘導体およびその製造法

Publications (1)

Publication Number Publication Date
ES2058057T3 true ES2058057T3 (es) 1994-11-01

Family

ID=26533894

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86116752T Expired - Lifetime ES2058057T3 (es) 1985-12-05 1986-12-02 Derivados de lancacidina y su produccion.

Country Status (8)

Country Link
EP (1) EP0226896B1 (es)
CN (1) CN1021910C (es)
BR (1) BR8605962A (es)
CA (1) CA1307269C (es)
DE (1) DE3689036T2 (es)
ES (1) ES2058057T3 (es)
HU (1) HU202235B (es)
MX (1) MX9203229A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855455A (en) * 1988-01-22 1989-08-08 W. R. Grace & Co.-Conn. Preparation of amino acid derivatives
US5210224A (en) * 1989-07-25 1993-05-11 Takeda Chemical Industries, Ltd. Process for preparing lankacidin carbamate derivatives
CN103113188A (zh) * 2011-11-17 2013-05-22 河北百灵威超精细材料有限公司 一种炔醇类化合物低成本的合成新方法
KR101349436B1 (ko) 2012-02-24 2014-02-05 고려대학교 산학협력단 해양 미생물 하헬라 제주엔시스의 제주엔올라이드 생합성 유전자 클러스터
CN109568676A (zh) * 2018-12-29 2019-04-05 张桂玲 一种抗菌超滑医用留置导管用材料

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE368705B (es) * 1969-03-31 1974-07-15 Takeda Chemical Industries Ltd
US4425356A (en) * 1980-11-29 1984-01-10 Takeda Chemical Industries, Ltd. Lankacidin derivatives used in swine husbandry
JPS58179496A (ja) * 1982-04-12 1983-10-20 Takeda Chem Ind Ltd ランカシジンの改良製造法
JPS58177949A (ja) * 1982-04-12 1983-10-18 Takeda Chem Ind Ltd ランカシジン群抗生物質包接化合物

Also Published As

Publication number Publication date
EP0226896B1 (en) 1993-09-15
CA1307269C (en) 1992-09-08
BR8605962A (pt) 1987-09-15
MX9203229A (es) 1992-07-01
HU202235B (en) 1991-02-28
DE3689036D1 (de) 1993-10-21
EP0226896A3 (en) 1988-12-07
DE3689036T2 (de) 1994-04-14
HUT45044A (en) 1988-05-30
CN86108176A (zh) 1987-10-21
CN1021910C (zh) 1993-08-25
EP0226896A2 (en) 1987-07-01

Similar Documents

Publication Publication Date Title
ES2056963T3 (es) Agentes antibacterianos.
DK62286D0 (da) Ikke-antibakterielle tetracyclinpraeparater med anticollagenolytiske egenskaber
DK441786A (da) Nucleosider, der kan anvendes terapeutisk
GR3025502T3 (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals.
MX9305269A (es) Utilizacion del receptor de il-4 para la terapia,la profilaxis y el diagnostico de enfermedades alergicas, viricas, parasitarias y bacterianas asi como de infecciones por hongos.
IT1237999B (it) Trattamento di malattie associate ad infezioni di hiv
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
DE3872063D1 (de) Zusammensetzung mit anregender wirkung fuer die haare.
SE503436C2 (sv) Pyroglutamidderivat
ES2058057T3 (es) Derivados de lancacidina y su produccion.
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
MY101875A (en) Lankacidin derivatives and production thereof.
ATE117318T1 (de) Aus blaualgen hergestellte biologisch aktive verbindungen.
DE3877499D1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
IT7828549A0 (it) Composizione terapeutica per il trattamento di infezioni e malattie di animali da allevamento.
MX9202938A (es) Composicion para la profilaxis o el tratamiento de la disenteria del ganado porcino y para aumentar su productividad.
SE7707274L (sv) Derivat av kinoxalin-1-4-dioxider och forfarande for framstellning derav
EP0343258A4 (en) Agent for prophylaxis and treatment of virally infected diseases.
IT7848884A0 (it) Composizione veterinaria utile in particolare nella cura delle malattie batteriche e protozoiche del pollame
SU1602007A1 (ru) 6-(4,5-Дифенилтиенил-2)-3-тиа-1,2,4-триазин-5-он, проявляющий противовоспалительную и антимикробную активность
DK31292D0 (da) Treatment and prophylaxis of diseases caused by parasites or bacteria

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 226896

Country of ref document: ES